Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Cash from Investing Activities (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Cash from Investing Activities for 10 consecutive years, with $36.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 196.18% to $36.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.8 million through Dec 2025, down 21.21% year-over-year, with the annual reading at $103.8 million for FY2025, 21.21% down from the prior year.
  • Cash from Investing Activities hit $36.4 million in Q4 2025 for Rocket Pharmaceuticals, down from $93.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $93.6 million in Q3 2025 to a low of -$140.8 million in Q4 2023.
  • Historically, Cash from Investing Activities has averaged $4.3 million across 5 years, with a median of $27.3 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: soared 1008.04% in 2021 and later plummeted 743.89% in 2022.
  • Year by year, Cash from Investing Activities stood at $16.9 million in 2021, then crashed by 743.89% to -$108.6 million in 2022, then decreased by 29.67% to -$140.8 million in 2023, then surged by 73.1% to -$37.9 million in 2024, then surged by 196.18% to $36.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RCKT at $36.4 million in Q4 2025, $93.6 million in Q3 2025, and $31.8 million in Q2 2025.